jama naion semaglutide A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Semaglutide and Eye Health: A

Other options include sulfonylureas (glibenclamide, gliclazide), which stimulate insulin secretion but carry risks of hypoglycaemia and weight gain

This Harvard Medical School Continuing Education video examines these key questions: What role do GLP1 receptor agonists ...

Break free from the guilt and frustration of past attempts and embrace modern tools that make change effortless At Unfiltered Medical Spa, were passionate about offering these transformative tools to help you achieve sustainable weight loss

We asked top weight-loss experts whether these new meds are worth the hype

Your dose may increase as needed, but your price remains stable, making long-term treatment financially predictable

The combination of GLP-1 and GIP activation explains why dual agonists like Tirzepatide outperform single GLP-1 agonists for both weight and glucose outcomes